Margareth Jorvid | Board Member
Elicera Therapeutics

Margareth Jorvid, Board Member, Elicera Therapeutics

Margareth Jorvid – MSc Pharm, MSc MTRA, MBA, FTOPRA Elicera Therapeutics AB Board Member Margareth Jorvid has over 30 years of experience in Regulatory Affairs and has worked at the Swedish Medical Products Agency (MPA) as well as large and small pharmaceutical and biotech companies, such as Roussel Nordiska, Hoechst Marion Roussel (in Stockholm and Paris, France) and Neopharma. Since 2006, consultant in regulatory affairs and QA for pharmaceuticals, ATMP (cell- and gene therapies), medical devices and combination products through her company Methra Uppsala AB, LSM group. She holds a MSc Pharm from Uppsala University, a MBA from Stockholm School of Economics, Sweden and a MSc MTRA from Cranfield University, UK.

Appearances:



Advanced Therapies USA 2025 - Day 2 @ 09:45

Keynote Panel Discussion: Overview of the current regulatory landscape for cell & gene therapies

Advanced Therapies USA 2025 - Day 2 @ 14:05

Panel Discussion: IND preparedness for cell & gene therapies: Overcoming regulatory challenges

Advanced Therapies USA 2025 - Day 2 @ 15:20

The Importance of Interacting with Regulators

last published: 28/May/25 08:55 GMT

back to speakers

Get Involved with the Advanced Therapies Congress

 

To sponsor or exhibit


Natasha Bangle
natasha.bangle@terrapinn.com
+44 20 3545 5515


Joshua Lloyd
Josh.Lloyd@terrapinn.com
+44 20 4614 9423

 

To speak


Chris Shanks
chris.shanks@terrapinn.com
+44 20 8152 7604